Owns a range of famous brands, such as “999”, “CR Double Crane”, “CR Jiangzhong”, “Dong-E-E-jiao”, “Boya”, and “Zizhu” 

China’s leading integrated pharmaceutical company

Strengthen the biomedical industry, promote inheritance and innovation of traditional Chinese medicine, and strengthen the layout of the whole industrial chain

Business spans over 29 provinces, autonomous regions and municipalities

Annual turnover exceeds HK$200 billion

China’s top 3 pharmaceutical commercial enterprises in terms of business scale

Owns 187 logistics centers and 663 retail pharmacies

On BrandZ’s Top 100 Most Valuable Chinese Brands for several consecutive years

Boast hundreds of products,including 24 ones with annual sales of over RMB100 million

have won the first in the cold and cough category (proprietary Chinese medicine) for many years.

Ranks the 14th among Top 100 Chinese Chemical Companies

Builds four platforms of generic drugs, infusions, differentiated drugs and innovative drugs

Deeply involves in chronic diseases, infusions, pediatrics, nephrology, and psychiatric/neurological areas

Owns 18 products sold over RMB100 million

Listed on World Brand Lab’s “China 500 Most Valuable Brands” for 19 consecutive years, with a brand value of RMB32.258 billion in 2022

Jiangzhong Jianwei Xiaoshi Tablet has been No. 1 proprietary Chinese medicine (digestive) for 19 consecutive years

192 medical institutions with over 27,100 beds available

17 tertiary hospitals, 31 secondary hospitals, 144 primary hospitals and community organizations